Apoptosis regulation in adrenocortical carcinoma

Apoptosis evading is a hallmark of cancer. Tumor cells are characterized by having an impaired apoptosis signaling, a fact that deregulates the balance between cell death and survival, leading to tumor development, invasion and resistance to treatment. In general, patients with adrenocortical carci...

Full description

Bibliographic Details
Main Authors: Sofia S Pereira, Mariana P Monteiro, Sonir R Antonini, Duarte Pignatelli
Format: Article
Language:English
Published: Bioscientifica 2019-05-01
Series:Endocrine Connections
Subjects:
Online Access:https://ec.bioscientifica.com/view/journals/ec/8/5/EC-19-0114.xml
id doaj-f69ea83795f745cbb63e6acf3574b25a
record_format Article
spelling doaj-f69ea83795f745cbb63e6acf3574b25a2020-11-25T00:26:00ZengBioscientificaEndocrine Connections2049-36142049-36142019-05-0185R91R104https://doi.org/10.1530/EC-19-0114Apoptosis regulation in adrenocortical carcinomaSofia S Pereira0Mariana P Monteiro1Sonir R Antonini2Duarte Pignatelli3Instituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto, Porto, Portugal; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal; Endocrine, Cardiovascular & Metabolic Research, Department of Anatomy, Multidisciplinary Unit for Biomedical Research (UMIB), Instituto de Ciências Biomédicas Abel Salazar, University of Porto (ICBAS/UP), Porto, PortugalEndocrine, Cardiovascular & Metabolic Research, Department of Anatomy, Multidisciplinary Unit for Biomedical Research (UMIB), Instituto de Ciências Biomédicas Abel Salazar, University of Porto (ICBAS/UP), Porto, PortugalDepartment of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, BrazilInstituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto, Porto, Portugal; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal; Department of Endocrinology, Hospital S. João, Porto, PortugalApoptosis evading is a hallmark of cancer. Tumor cells are characterized by having an impaired apoptosis signaling, a fact that deregulates the balance between cell death and survival, leading to tumor development, invasion and resistance to treatment. In general, patients with adrenocortical carcinomas (ACC) have an extremely bad prognosis, which is related to disease progression and significant resistance to treatments. In this report, we performed an integrative review about the disruption of apoptosis in ACC that may underlie the characteristic poor prognosis in these patients. Although the apoptosis has been scarcely studied in ACC, the majority of the deregulation phenomena already described are anti-apoptotic. Most importantly, in a near future, targeting apoptosis modulation in ACC patients may become a promising therapeutic.https://ec.bioscientifica.com/view/journals/ec/8/5/EC-19-0114.xmladrenocortical tumorsadrenocortical carcinomasapoptosismolecular deregulations
collection DOAJ
language English
format Article
sources DOAJ
author Sofia S Pereira
Mariana P Monteiro
Sonir R Antonini
Duarte Pignatelli
spellingShingle Sofia S Pereira
Mariana P Monteiro
Sonir R Antonini
Duarte Pignatelli
Apoptosis regulation in adrenocortical carcinoma
Endocrine Connections
adrenocortical tumors
adrenocortical carcinomas
apoptosis
molecular deregulations
author_facet Sofia S Pereira
Mariana P Monteiro
Sonir R Antonini
Duarte Pignatelli
author_sort Sofia S Pereira
title Apoptosis regulation in adrenocortical carcinoma
title_short Apoptosis regulation in adrenocortical carcinoma
title_full Apoptosis regulation in adrenocortical carcinoma
title_fullStr Apoptosis regulation in adrenocortical carcinoma
title_full_unstemmed Apoptosis regulation in adrenocortical carcinoma
title_sort apoptosis regulation in adrenocortical carcinoma
publisher Bioscientifica
series Endocrine Connections
issn 2049-3614
2049-3614
publishDate 2019-05-01
description Apoptosis evading is a hallmark of cancer. Tumor cells are characterized by having an impaired apoptosis signaling, a fact that deregulates the balance between cell death and survival, leading to tumor development, invasion and resistance to treatment. In general, patients with adrenocortical carcinomas (ACC) have an extremely bad prognosis, which is related to disease progression and significant resistance to treatments. In this report, we performed an integrative review about the disruption of apoptosis in ACC that may underlie the characteristic poor prognosis in these patients. Although the apoptosis has been scarcely studied in ACC, the majority of the deregulation phenomena already described are anti-apoptotic. Most importantly, in a near future, targeting apoptosis modulation in ACC patients may become a promising therapeutic.
topic adrenocortical tumors
adrenocortical carcinomas
apoptosis
molecular deregulations
url https://ec.bioscientifica.com/view/journals/ec/8/5/EC-19-0114.xml
work_keys_str_mv AT sofiaspereira apoptosisregulationinadrenocorticalcarcinoma
AT marianapmonteiro apoptosisregulationinadrenocorticalcarcinoma
AT sonirrantonini apoptosisregulationinadrenocorticalcarcinoma
AT duartepignatelli apoptosisregulationinadrenocorticalcarcinoma
_version_ 1725346456019140608